Antioxidant and lysosomotropic properties of acridine-propranolol: Protection against oxidative endothelial cell injury

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 2, 2002, Pages 129-137

  Dickens, Benjamin F ^a   Weglicki, William B ^a   Boehme, Patricia A ^a   Mak, Tong I ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acridine propranolol; Antioxidant; Cultured endothelial cell; Glutathione loss; Lysosomotropic; MTT cell survival

Indexed keywords

9 ACRIDINYLAMINO PROPRANOLOL; ACRIDINE DERIVATIVE; ACRIDINE ORANGE; ALPHA TOCOPHEROL; ANTIOXIDANT; CELL MARKER; GLUTATHIONE; HYDROXYL RADICAL; PROPRANOLOL; PROPRANOLOL DERIVATIVE; SUPEROXIDE; UNCLASSIFIED DRUG;

ALKALINIZATION; ANIMAL CELL; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL LOSS; CELL PH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HEART MUSCLE INJURY; LIPID PEROXIDATION; LYSOSOME; MALE; MICROSOME MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0036487269     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2001.1495     Document Type: Article

References (39)

1. Anderson R, Ramafi G, Theron AJ. Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils. Biochem Pharmacol 1996; 52: 341-349.
2. Welman E. Stabilization of lysosomes in anoxic myocardium by propranolol. Br J Pharmacol 1979; 65: 479-482.
3. Khaper N, Rigatto C, Seneviratne C, Li T, Singal PK. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol 1997; 29: 3335-3344.
4. Peracchia F, Polentarutti N, Colotta F, Mussoni L. Increased expression of urokinase mRNA in bovine aortic endothelial cells treated with propranolol. Biochem Biophys Res Commun 1989; 160: 977-981.
5. Mota-Filipe H, Castro M, Giao TRJ. Effect of DL-propranolol on nitric oxide production in perfused rat hindquarters. Eur J Pharmacol 1992; 213: 227-233.
6. Mak IT, Weglicki WB. Beta blockers with antioxidant properties: from propranolol to carvedilol. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C (eds). Free Radicals, Lipoprotein Oxidation and Atherosclerosis: Biological and Clinical Aspects. London: The Richelieu Press, 1995; 457-472.
7. Chobanian AV, Brecher P, Chan C. Effects of propranolol on atherogenesis in the cholesterol-fed rabbit. Circ Res 1985; 56: 755-762.
8. Kramer JH, Misík V, Weglicki WB. Lipid peroxidation-derived free radical production and postischemic myocardial reperfusion injury. Ann NY Acad Sci 1994; 723: 180-196.
9. Weglicki WB, Freedman AM, Bloom S, Atrakchi AH, Cassidy MM, Dickens BF, Mak IT. Antioxidants and the cardiomyopathy of Mg-deficiency. Am J Cardiovascul Pathol 1992; 4: 210-215.
10. Freedman AM, Cassidy MM, Weglicki WB. Propranolol reduces cardiomyopathic injury induced by magnesium deficiency. Magnes Trace Elem 1992; 10: 348-354.
11. Brunk U, Cadenas E. The potential intermediate role of lysosomes in oxygen free radical pathology. APMIS 1988; 96: 3-13.
12. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T. Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin, and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994; 12: 289-303.
13. Starke PE, Gilbertson JD, Farber JL. Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide. Biochem Biophys Res Commun 1985; 133: 371-379.
14. Gannon DE, Varani J, Phan SH, Ward JH, Kaplan J, Till GO, Simon RH, Ryan US, Ward PA. Source of iron in neutrophil-mediated killing of endothelial cells. Lab Invest 1987; 57: 37-44.
15. Öllinger K, Brunk UT. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic Biol Med 1995; 19: 565-574.
16. Cramb G. Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems. Biochem Pharmacol 1986; 35: 1365-1372.
17. Mak IT, Murphy A, Hopper A, Witiak D, Ziemniak J, Weglicki WB. Potent inhibitory activities of hydrophobic aci-reductones against membrane and human LDL oxidation. Biochem Pharmacol 1998; 55: 1921-1926.
18. Mak IT, Weglicki WB. Membrane antiperoxidative activities of d-propranolol, 1-propranolol, and dimethyl quaternary propranolol (UM-272). Pharmacol Res 1992; 25: 25-30.
19. Mak IT, Kramer JH, Weglicki WB. Potentiation of free radical-induced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles. J Biol Chem 1986; 261: 1153-1157.
20. Mak IT, Weglicki WB. Antioxidant activity of calcium channel blocking drugs. Methods Enzymol 1994; 234: 620-630.
21. Mak IT, Komarov AM, Wagner TL, Stafford RE, Dickens BF, Weglicki WB. Enhanced NO production during Mg-deficiency and its role in mediating red cell glutathione loss. Am J Physiol 1996; 271: C385-C390.
22. Mak IT, Boehme P, Weglicki WB. Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation. Biochem Pharmacol 1995; 50: 1531-1534.
23. Mak IT, Zhang J, Weglicki WB. Cytoprotecitve properties of nisodipine and amlodipine against oxidative endothelial cell injury. NY Acad Sci 2000; 899: 403-406.
24. Melamed E, Lahav M, Atlas D. Beta-adrenergic receptors in rat myocardium: direct detection by a new fluorescent beta-blocker. Experientia 1976; 32: 1387-1389.
25. Melamed E, Luhar M, Atlas D. Histochemical labeling of beta-adrenergic receptors in the mouse central nervous system by 9-amino-acridine propranolol. Neurology 1978; 28: 850-853.
26. Mak IT, Boehme P, Weglicki WB. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels. Circ Res 1992; 70: 1099-1103.
27. Freedman AM, Kramer JH, Mak IT, Cassidy MM, Weglicki WB. Propranolol preserves ultrastructure in adult cardiocytes exposed to anoxia/reoxygenation: a morphometric analysis. Free Rad Biol Med 1991; 11: 197-206.
28. Mak IT, Kramer JH, Freedman AM, Tse SYH, Weglicki WB. Oxygen free radical-mediated injury of myocytes-protection by propranolol. J Mol Cell Cardiol 1990; 22: 687-695.
29. Kramer JH, Mak IT, Freedman AM, Weglicki WB. Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an antiradical mechanism. J Mol Cell Cardiol 1991; 23: 1231-1244.
30. Fabisiak JP, Vesell ES, Rannels DE. Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. II. Receptor-independent accumulation of beta adrenergic antagonists and other cationic amphiphilic drugs in lamellar bodies. J Pharmacol Exp Ther 1987; 241: 728-735.
31. Howell RE, Albelda SM, Daise ML, Levine EM. Characterization of beta-adrenergic receptors in cultured human and bovine endothelial cells. J Appl Physiol 1988; 65: 1251-1257.
32. Steinberg SF, Jaffe EA, Bilezikian JP. Endothelial cells contain beta adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1984; 325: 310-313.
33. Summers RJ, Molenaar P, Stephenson JA, Jones CR. Autoradiographic localization of receptors in the mammalian cardiovascular system. Clin Exp Pharmacol Physiol 1987; 14: 437-447.
34. Smedsrod B, Malmgren M, Ericsson J, Laurent TC. Morphological studies on endocytosis of chondroitin sulphate proteoglycan by rat liver endothelial cells. Cell Tissue Res 1988; 253: 39-45.
35. Ohkuma S, Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 1981; 90: 656-664.
36. Styrt B, Klempner MS. Lysosomotropic amines modulate neutrophil calcium homeostasis. J Cell Physiol 1988; 135: 309-316.
37. Lloyd JB, Cable H, Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem Pharmacol 1991; 41: 1361-1363.
38. Balla G, Jacob HS, Nath K, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992; 267: 18148-18153.
39. Brieland JK, Clarke SJ, Karmiol S, Phan SH, Fantone JC. Transferrin: a potential source of iron for oxygen free radical-mediated endothelial cell injury. Arch Biochem Biophys 1992; 294: 265-270.